Voriconazole antifungal prophylaxis in children with malignancies: A nationwide study
Journal of Pediatric Hematology/Oncology Jan 24, 2018
Pana ZD, et al. - The safety of antifungal prophylaxis (AFP) with voriconazole (VRC) was evaluated among pediatric hematology/oncology patients in this nationwide study. In these pediatric patients, VRC prophylaxis seemed to be well tolerated.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
